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THE EFFECTS OF GENETIC VARIATION ON ENDOCHONDRAL BONE 
FORMATION IN FRACTURE HEALING OF RACHITIC MICE  
BRENNA HOGUE 
 
ABSTRACT 
 
Phosphate (Pi) is essential for healthy bone growth as well as normal 
fracture repair. Studies have shown that when animals are phosphate deficient 
normal fracture healing is interrupted. Although phosphate deficiency has been 
shown to impair fracture healing, it is unknown how different genetic factors 
interact with phosphate deficiency to disrupt healing. Furthermore, it is unknown 
if upon replenishing phosphate in the diet healing will be re-initiated or if the 
deficiencies will persist irreversibly to prolong the healing of the bones. To 
assess how genetic factors interact with phosphate deficiency, fractures were 
generated in three genetically distinct strains of mice that had previously been 
shown to have different patterns of endochondral bone formation.  Phosphate 
deficiency was initiated two days prior to fracture and was then maintained for a 
15 day period covering the normal duration of endochondral bone development. 
To assess if replenishing phosphate could rescue genetic expression of deficient 
healing, normal phosphate was re-introduced into the diet after 15 days of 
deficiency and bone healing was allowed to continue until 35 days post fracture.  
Messenger RNA expression for marker genes for cartilage and bone formation 
was assessed by quantitative reverse transcriptase-polymerase chain reaction 
(qRT-PCR) analysis over this time course of healing. 
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Structural properties, callus mineralization and cartilage contents were 
assessed by micro-computed tomography and contrast agent enhanced micro-
computed tomography (CECT). Torsional mechanical testing was used to 
measure bone strength. To assess if replenishing phosphate could rescue 
mineralization and biomechanical properties of deficient healing, normal 
phosphate was re-introduced after 15 days of deficiency and bone healing was 
allowed to continue until 21 days post fracture. 
The biological assessment of fracture healing showed that all three 
genetic strains had impaired expression of both cartilage and bone associated 
genes during the period of phosphate deficiency. Once phosphate was returned 
to the diet, however, the osteogenesis genes showed a burst of late expression 
in all three strains.  Interestingly, torsional testing of the bones showed that 
phosphate deficient/replenished groups were all stronger but also more brittle 
than the bones of control mice. Micro-computed tomography demonstrated that 
bone mineral density was slightly higher in the phosphate deficient mice but the 
bone mineral density standard deviation in the calluses were also higher 
indicating that the mineralization within the healing calluses was unevenly 
distributed in the phosphate deficient/replenished group. Lastly, contrast agent 
enhanced computed tomography data showed that the overall callus tissue 
mineral density was lower in phosphate deficient/replenished calluses due to the 
greater cartilage in the phosphate deficient/replenished calluses.  
 vii 
These results suggest that the increase strength in the phosphate 
deficient/replenished calluses is due to the burst of expression in osteogenesis 
genes that led to the rapid mineralization of the fracture gap in order to 
compensate for fracture instability due to the phosphate restriction. They also 
show that a gross metabolic alteration supersedes all other aspects of genetic 
variably in endochondral development. Finally, they show that even though 
fracture healing may be greatly delayed by phosphate deficiency, replacement of 
phosphate after deficiency leads to rapid regain in function. Future studies need 
to be carried out to determine if longer time lengths of phosphate deficiency can 
be rescued upon reintroduction of phosphate.  
 viii 
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INTRODUCTION 
 
Fracture healing is an intricate and fascinating process that affects our 
lives daily. Bone is a unique tissue in that it is continually renewed and 
remodeled throughout our lives. Although the majority of fractures heal without 
any associated problems, approximately 5 to 10 % of fractures in the United 
States exhibit delayed or impaired healing (Einhorn, 1995). Hypophosphatemia 
leads to rickets and osteomalacia, the latter of which results in decreased 
biomechanical integrity of bones, accompanied by poor fracture healing (Wigner 
et al., 2010). Since hypophosphatemia has a clear link to deficiencies in fracture 
healing, the aim of this study was to define the mechanisms of fracture healing 
that are being affected by the loss of phosphate. Also, little is known about how 
phosphate deficiency affects healing in genetically distinct animals. This study 
also aims to shed light on differences in deficient fracture healing due to genetic 
variation. 
 
The Process of Normal Fracture Healing 
Bone has an incredible capacity for repair and regeneration after injury. 
Repair simply restores the continuity of the injured tissues. In contrast, 
regeneration involves the differentiation of new cells and the formation of new 
bone tissue that results in an overall increase in the volume of new skeletal 
tissues (Ai-Aql et al., 2008). There are four locations shown in Figure 1 that are 
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contiguous with the fracture site and interact with each other to start the process 
of fracture healing.  These locations are the external soft tissue, the periosteum, 
the cortical bone, and the bone marrow space.    
 
Figure 1.  Locations Involved in Fracture Healing.  Figure taken from Einhorn, 
1995. 
 
The initial response to a fracture occurs in the bone marrow space, where 
a hematoma forms due to damage to the blood vessels in the surrounding area 
(Einhorn, 1995).  This stage is then followed by a removal of damaged blood 
vessels in the area, establishment of a fibrin clot, and a rearrangement of cellular 
densities in the bone marrow space to create a high cell density adjacent to the 
fracture site (Brighton and Hunt, 1991).  Histologically, fracture healing can be 
classified as either primary fracture healing or secondary fracture healing. Both 
the primary and secondary fracture healing processes work in concert to promote 
union of the bone at the fracture gap (Gerstenfeld et al., 2003).  Primary fracture 
healing involves a direct attempt by the cortex to heal itself after interruption 
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without the formation of a fracture callus (Bernstein, 2011).  Primary healing only 
works when the edges are touching exactly and since touching edges are not 
common, primary healing is the less prominent process seen in typical fracture 
healing. However, direct healing can be achieved through rigid fixation of the 
bone at the fracture, allowing cortical bone to remain in contact (Bernstein, 
2011).  Osteoclasts will then proceed to resorb bone and reform the Haversian 
canals, allowing blood vessels, that contain endothelial and perivascular 
mesenchymal cells that develop into osteoprogenitor cells, to enter the area of 
injured bone (Lee, Choi, Behrens, DeFouw, & Einhorn, 1998).   
Secondary fracture healing is more likely the major process by which most 
forms of fractures heal. Secondary bone healing involves the classical stages of 
injury, hemorrhage inflammation, primary soft callus formation, callus 
mineralization, and callus remodeling (Bernstein, 2011). In secondary fracture 
healing, the external soft tissue and the periosteum, which contains 
osteoprogenitor cells and uncommitted mesenchymal cells, re-initiate the 
processes of embryonic intramembranous and endochondral bone formation 
(Einhorn, 1998).  
During the first few days of fracture healing, intramembranous bone 
formation occurs and bone is generated without the formation of a cartilage 
framework (Bernstein, 2011). Intramembranous bone formation occurs internal to 
the periosteum at the proximal and distal edges of the callus and forms hard 
callus (Dimitriou et al., 2005) 
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After the first few days post fracture, endochondral bone formation initiates 
to stabilize the fracture and the forming callus. Endochondral bone formation 
usually occurs external to the periosteum in regions that are mechanically less 
stable and immediately adjacent to the fracture site (Dimitriou et al., 2005). 
Mesenchymal cells will differentiate into chondrocytes in areas lacking an 
immediate blood supply.  The chondrocytes will generate the callus to act as 
scaffolding around the fracture site and to stabilize the two segments of bone.  
Once this initial stability is established blood vessels will be recruited into the 
callus, and the osteoblasts will initiate an intramembranous bone formation 
process to create woven bone.  Once there is a sufficient amount of woven bone, 
endochondral bone formation occurs (Gerstenfeld et al., 2003) 
The distinguishing feature of endochondral bone formation is the 
development of a cartilage scaffold called a callus (Bernstein, 2011). 
Endochondral bone growth is regulated by the secretion of molecules by 
perichondrial cells near the fracture zone (Kronenberg, 2005). The best 
characterized of these molecules is parathyroid hormone-related protein 
(PTHrP). Figure 2 below shows the feedback loop through which PTHrP affects 
endochondral bone formation. 
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Figure 2. Ihh and PTHrP coordinate growth cartilage regulation. PTHrP 
made at the end of the bone by perichondrial cells and chondrocytes acts on 
chondrocytes to keep them proliferating. Ihh acts on chondrocytes to increase 
their rate of proliferation, to hasten the conversion of round proliferating 
chondrocytes to flat proliferating chondrocytes, and to increase the production of 
PTHrP. Ihh also acts on perichondrial cells to direct them along the osteoblast 
lineage. Figure from Kronenberg et al. 2007 
 
In early stages of bone development, PTHrP is secreted from 
perichondrial cells and acts to keep the chondrocytes in the cell cycle. In 
response to PTHrP as well as other signaling molecules, chondrocytes in the 
center of the bone anlagen proliferate and secrete a matrix rich in collagen, type 
II, and aggrecan (Kronenberg et al., 2007). When the mass of chondrocytes 
reaches a characteristic size, different for each bone, chondrocytes in the center 
of the anlagen stop proliferating and then hypertrophy. These postmitotic, 
hypertrophic chondrocytes secrete a matrix rich in collagen, type X, and 
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mineralize the matrix that surrounds them (Kronenberg et al., 2007). 
As endochondral bone growth progresses, the cartilage of the callus 
becomes calcified and is replaced by woven bone (Bernstein, 2011). Once the 
woven bone, which is also referred to as immature bone, is created, the next 
process that occurs is the formation of lamellar, or mature bone, by remodeling 
the woven bone (Gerstenfeld et al., 2003). The final step involves the resorption 
and remodeling of the mineralized cartilage and excess bone. Remodeling of the 
callus leads to restoration of the anatomic and biomechanical properties of the 
original skeletal element (Wigner et al., 2010). Figure 3 provides a histologic 
overview of the various stages observed in fracture healing. 
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Figure 3.  Histology of Fracture Healing.  Specimens utilized for histologic 
analysis came from the sagittal plane of a mouse tibia that was fractured in the 
transverse plane.  Magnification is 200X.  Safranin O and fast green were the 
stains used.  A. 24 hours post fracture.  B. Preliminary response of the 
periosteum with endochondral formation 7 days after fracture.  Arrows point to 
vascular ingrowth to fracture site.  C.  Primary bone formation 14 days following 
fracture.  Arrows indicate new vascular ingrowth.  Inset shows osteoclast 
resorbing calcified cartilage.  D. 21 days after fracture.  Inset depicts osteoclast 
resorbing primary bone.  Figure taken from Gerstenfeld et al., 2006  
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The length of time required to complete this repair process varies 
depending on many factors such as the location of the fracture site as well as the 
relative stability of the bone during healing. In mice, the healing process usually 
takes approximately three weeks, but in larger animals the process can take as 
long as three months before healing is complete and biomechanical properties of 
the bone are fully restored (Gerstenfeld et al., 2006, Morgan et al., 2008)  
 
The Role of Phosphate in Endochondral Bone Formation and Fracture Healing  
During normal endochondral bone formation processes that facilitate long 
bone growth, cells in the growth plate progress into a maturation process that 
results in an increase in chondrocyte number and volume and the mineralization 
of the matrix (Staines et al., 2013). Afterwards, the terminally differentiated cells 
undergo apoptosis and the mineralization matrix undergoes resorption and 
replacement with bone. (Adams and Shapiro, 2002). During both normal long 
bone growth and fracture healing endochondral chondrocytes proliferate and 
become hypertrophied and as the cells become hypertrophic, they increase their 
volume five- to 12- fold and elevate three-fold the total amount of territorial extra- 
cellular matrix (Hunziker, 1994). As the cartilage becomes mineralized, the 
terminally differentiated hypertrophic chondrocytes are removed from the 
cartilage by apoptosis (Li et al., 2002). 
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Figure 4. Organization of the mammalian growth plate. The growth plate is 
classically divided into four major zones. The approximate extent of each of 
these regions is shown in this longitudinal section of a rat growth plate. The most 
superficial zone, resting cartilage, contains chondroprogenitor cells. These cells 
serve as the stem chondrocytes that then further differentiate into proliferative 
chondroblasts of the growth plate. In the proliferative cartilage zone, 
chondrocytes divide rapidly in a direction that is parallel to the long axis of the 
bone, thereby providing longitudinal appositional growth. In the hypertrophic 
cartilage zone, chondrocytes cease to divide and begin to increase their 
intracellular volume, therefore achieving some interstitial growth. Toward the 
bottom of the growth plate, the hypertrophic chondrocytes induce calcification of 
the extra- cellular matrix. It is in this zone that apoptotic cells are evident. Figure 
taken from Adams and Shapiro, 2002. 
 
 There are a variety of substances considered to be triggers for the 
initiation of the apoptotic pathway in hypertrophic chondrocytes. Phosphate in 
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particular is one of the best studied of these apoptogens. With respect to tissue 
mineralization the hydroxyapatite, once solubilized, creates an apparent 
elevation in the local Ca2+ and phosphate (Pi) ion concentration (Adams and 
Shapiro, 2002). Investigators demonstrated that phosphate was capable of 
activating apoptosis in chondrocytes at nearly physiological levels (Adams and 
Shapiro 2002). Thus, treatment of hypertrophic chondrocytes with phospahte 
induced death in a dose and time dependent manner (Mansfield et al., 1999). 
Specifically, studies of cell death with phosphate as an apoptogen indicate that 
the anion is transported into the cytosol via a Na+/Pi transporter and 
subsequently, there is activation of caspases, generation of NO, and a decrease 
in the thiol reserve (Adams and Shapiro. 2002) which are all molecular 
mechanisms of apoptosis. Furthermore, in vitro analyses in primary murine 
chondrocytes demonstrate that phosphate mediates hypertrophic chondrocyte 
apoptosis by activating the caspase-9-dependent mitochondrial pathway and 
studies in mice treated with a caspase-9 inhibitor confirm the critical importance 
of the mitochondrial pathway in growth plate maturation in vivo (Sabbagh, 
Carpenter, & Demay, 2005).   
Hypophosphatemia leads to rickets, which results in decreased 
biomechanical integrity of bones, accompanied by poor fracture healing (Wigner 
et al., 2010). Rickets is a softening of bones in immature mammals due to 
deficiency or impaired metabolism of vitamin D, phosphorous or calcium 
potentially leading to fractures and deformity. Investigations in murine models of 
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X-linked hypophosphatemia and hereditary vitamin D–resistant rickets 
demonstrate that rachitic expansion of the hypertrophic chondrocyte layer in the 
growth plate is a consequence of impaired apoptosis of these cells (Sabbagh, 
Carpenter, & Demay, 2005). Molecular analyses reveal that increases in 
extracellular phosphate activate the mitochondrial apoptotic pathway in 
hypertrophic chondrocytes, a process that is required for normal endochondral 
bone formation...thus, while phosphate is required for mineralized matrix 
formation, it also plays a regulatory role in terminal differentiation of hypertrophic 
chondrocytes (Wigner et al., 2010). In addition to Rickets, congenital and 
acquired hypophosphatemic states are associated with impaired fracture healing 
(Chapuy et al., 1992) thus indicating hypophosphatemia as a condition 
necessary for study for its potential role in deficient fracture repair. 
 
Genetic Variation in Fracture Healing 
Bone healing after injury is a complex trait that cannot simply be studied 
using one genetic model for fracture healing therefore, it is necessary to examine 
bone healing in the context of how intact polygenic networks influence cellular 
activity during the healing process (Jepsen et al., 2008). Therefore, identifying 
aspects of genetic background that are both prognostic and/or diagnostic of 
variation in the rate of fracture healing will have important clinical value in better 
defining when an individual can resume normal activities and weight bearing after 
fracture (Jepsen et al., 2008). 
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In prior studies the A/J (AJ), C3H/HeJ (C3) and C57BL/6J (B6) mouse 
models have been used to examine the genetic relationship between the repair 
mechanisms underlying the timing as well as expression of proteins and 
transcription factors involved in fracture healing, specifically, the B6 mouse 
exhibits a faster progression of endochondral bone formation compared to the 
other commonly used A/J and C3H/HeJ strains of laboratory mice (Jepsen et al., 
2008).  
These models differ primarily in their temporal rates of development of 
cartilage as well as bone deposition.  Using transcriptomic assessments 
differences in the expression patterns of specific genes have been shown to be 
associated with different phenotypic properties of the bone as they heal (Jepsen 
et al., 2008).  The mice show differing patterns of expression have provided 
much information to the scientific community regarding the ways these mice heal 
from fractures at differing rates.  
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OBJECTIVES 
 
The hypothesis of this study was that genetic variation would have 
differing effects on the fracture healing in rachitic animals. To test this hypothesis 
mRNA expression, biomechanical strength measures, cartilage content, callus 
structure and mineral content were measured in three inbred strains of A/J (AJ), 
C3H/HeJ (C3) and C57BL/6J (B6) mice in which a rachitic state was generated 
by placing the mice on a phosphate deficient diet for 15 days.  We then assessed 
whether initial phosphate deficiency will irreversibility effect bone healing by 
replenishing the phosphate in the diet and assessing biomechanical measures of 
healing at 21 days post fracture.  
1) Messenger mRNA profiles for specific genes sets were used to identify 
the temporal differences in gene expression that are related to cartilage and 
bone development in the three strains of phosphate deficient/replenished mice as 
well as control mice.  Given the developmental differences of endochondral bone 
development in these genetically distinct mouse strains, this aim focuses on the 
molecular mechanisms of skeletal cell development and the mechanisms of 
regulation that will be affected by phosphate deficiency during fracture healing as 
well as after phosphate repletion. 
2) The affects the phosphate deficiency and phosphate repletion on regain 
of structural and biomechanical functional properties of the healing bones were 
assessed through the use of micro-computed tomography (micro-CT) and 
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torsional mechanical testing.  Differences observed in these measurements will 
elucidate which functional phenotypic processes of normal healing are being 
affected in the phosphate deficient mice. 
3) Lastly, the use of contrast agent enhanced micro-computed 
tomography (CECT) was used to quantify continued presence of cartilage in the 
healing calluses.  From this information researchers are able to determine if 
phosphate deficiency is related to the continued presence of cartilage in the 
healing callus and how the cartilage in the callus effects its phenotypic structural 
and biomechanical properties.  
Since neither the cellular nor the molecular basis for impaired fracture 
repair in this prolonged phosphate restriction condition has been examined, we 
undertook investigations to identify the mechanism by which hypophosphatemia 
leads to impaired skeletal repair. We further assessed if replenishment of 
phosphate in the diet would restore impaired healing. Gathering this data has the 
potential to elucidate new information about mechanisms of bone repair as well 
as providing basic knowledge to the scientific community that is interested in 
developing a treatment plan in humans who have impaired with fracture healing 
due to a rachitic state. 
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METHODS 
 
Study Design  
To test these hypotheses, A/J (AJ), C3H/HeJ (C3) and C57BL/6J (B6) 
strains of mice were placed on a phosphate deficient diet two days prior to 
fracture.  The mice used for RNA analysis remained on the phosphate deficient 
diet during fracture healing for 15 days depending on their designated time point 
for harvest after fracture. Mice that were designated for the 18, 21, 28 and 35 day 
harvests were subsequently returned to a normal diet after day 15 and given food 
containing standard dietary phosphate levels.  The study tested whether there is 
a time frame of phosphate deficiency that will prevent the normal fracture repair 
process from proceeding even after phosphate is returned to the diet.  Six mice 
were utilized for each time point and for each strain for evaluation totaling 18 
mice per time point as seen in Table 1. 
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Table 1.  Study Design mRNA Samples.  A total of two groups (including 
control) were utilized for the qPCR study. Six mice were used for each strain at 
each time point of evaluation except day 0 (3 mice per strain).  The time points 
ranged from 0 to 35 days and indicate the number of days after fracture.  The 
phosphate (Pi) deficient groups were placed on the restricted diet two days prior 
to fracture of the right femur.  Following completion of the 15 day phosphate 
restriction the mice were returned to a normal diet that included phosphate. 
 
 0 
Day 
3 
Day 
5 
Day 
7 
Day 
10 
Day 
14 
Day 
18 
Day 
21 
Day 
28 
Day 
35 
Day 
mRNA: 
Control 
Mice 
 
AJ:3 
B6:3 
C3:3 
AJ:6 
B6:6 
C3:6 
AJ:6 
B6:6 
C3:6 
AJ:6 
B6:6 
C3:6 
 
AJ:6 
B6:6 
C3:6 
 
AJ:6 
B6:6 
C3:6 
 
AJ:6 
B6:6 
C3:6 
AJ:6 
B6:6 
C3:6 
 
AJ:6 
B6:6 
C3:6 
AJ:6 
B6:6 
C3:6 
mRNA: 
15 Day Pi 
Restriction 
(15DR) 
Mice 
 AJ:6 
B6:6 
C3:6 
AJ:6 
B6:6 
C3:6 
AJ:6 
B6:6 
C3:6 
AJ:6 
B6:6 
C3:6 
AJ:6 
B6:6 
C3:6 
AJ:6 
B6:6 
C3:6 
AJ:6 
B6:6 
C3:6 
AJ:6 
B6:6 
C3:6 
AJ:6 
B6:6 
C3:6 
 
 For the micro-CT and mechanical testing portion of the study we chose to 
look at 12 mice from each strain all from post fracture day 21. For the contrast 
agent enhanced CT (CECT) portion of the study we used 9 mice from each strain 
all from the post fracture day 21. See table 2 for study design. 
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Table 2. Study Design micro-CT, mechanical testing, and CECT samples. A 
total of two groups (control and phosphate deficient) were utilized for the micro-
CT, mechanical testing, and CECT studies. For the micro-CT and mechanical 
testing studies twelve mice were used for each strain for each group. The 
asterisk (*) indicates that the same bones that were used for micro-CT scanning 
were then used directly after the scan as mechanical testing samples. For the 
Contrast Agent Enhanced CT (CECT) study nine mice were used for each strain 
in each group. 
 
 Micro-CT* 
Study 
Mechanical 
Testing* 
CECT 
Study 
Control 
Mice 
 
AJ:12 
B6:12 
C3:12 
AJ:12 
B6:12 
C3:12 
AJ:9 
B6:9 
C3:9 
15 Day Pi 
Restriction 
(15DR) Mice 
AJ:12 
B6:12 
C3:12 
AJ:12 
B6:12 
C3:12 
AJ:9 
B6:9 
C3:9 
 
We chose to focus on day 21 because at this time after fracture the callus 
should be completely mineralized with marked bone deposition (Gerstenfeld et 
al., 2006) so any deficiency in callus mineralization or bone formation caused by 
the phosphate deficiency should be apparent relative to control mice. 
 
Animals 
A total of 225 male mice (75 per strain) were used for this study. The 
strains of mice used were C57BL/6J (B6), the A/J (AJand the C3H/HeJ (C3) 
strains. All animals were from Jackson Laboratories (Bar Harbor, Maine) and 
were brought to the Boston University School of Medicine Laboratory Animal 
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Sciences Center (LASC) before being placed on the phosphate restrictive diet.  
At the time of enrollment and group designation all of the mice were 
approximately 10 weeks old.  Male mice were used in the study because of 
sexual dimorphism in skeletal structure and the effects that estrogen has on bone 
metabolism, both of which have the potential to alter and confound experimental 
measures (Seeman, 2001; Smith et al., 2008).  All of the animals were weighed 
at the time of surgery.  The weights of the mice ranged from 23 to 31 grams with 
an average weight of 26 grams.  
 
Phosphate Deficient Diet 
Special Custom Animal Research Diets were obtained by request from 
Harlan Laboratories® (Madison, WI).  The diet is TD.03486  EW Diet is 20% 
Lactose 0.6% Ca, Low P provided as a standard caloric formulation that was 
vitamin supplemented but deficient in phosphate.  Animals were placed on the 
diet two days prior to fracture of the right femur.  Phosphate deficient animals in 
time point enrollment groups later than 14 days were returned to the normal diet 
after 15 days on the phosphate deficient diet. 
 
Surgical Procedure 
All of the surgical procedures conducted on the mice took place at the 
LASC following a protocol that was reviewed and subsequently approved by the 
Institutional Animal Care and Use Committee (IACUC).  The LASC facility is 
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accredited by the American Association for the Accreditation of Laboratory 
Animal Care (AAALAC) and licensed by the United States Department of 
Agriculture (USDA).  Members of the Boston University School of Medicine who 
are conducting research on laboratory animals under approved federal guidelines 
utilize this facility. 
Animals were anesthetized by inhalation of an isoflourane and oxygen 
mixture.  The isoflourane was 5 % of the inhalant until the animals were 
anesthetized and then they were maintained at 3 % during the procedure using a 
nose cone throughout the duration of the surgical procedure.  A dose of .1 mg/kg 
of Buprenex® (buprenorphine) and anti-biotic Baytril® at dosage of 0.01 mg/kg 
was delivered subcutaneously prior to the initiation of the surgery to ensure for 
immediate post-operative pain management and infection prophylaxis.  The right 
knee was shaved with an electric shaver and aseptically prepared by scrubbing 
the area with gauze soaked in Betadine® (povidone-iodine). 
A median longitudinal skin incision was made over the patellar ligament of 
the knee.  The femoral condyle was exposed and a hole was created by the 
insertion of a 23 G spinal needle. The 23 G spinal needle pin was inserted 
through the hole and down the femur until it contacted the proximal physis.  The 
spinal needle pin was then cut at the femoral condyle and was pushed under the 
condylar surface.  The wound was then closed using three to four absorbable 
sutures.  Once the pin was placed in the femur, the fractures were generated 
using a modification of the fracture machine described by Marturano et al., 2008. 
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The fracture machine is a device that has a blunt blade that is spring loaded and 
is driven by release of a weight from a set height.  The femur of the animals was 
positioned on a mount on two points under the blunt tipped blade, just touching 
the muscle over the lateral side of the mid-diaphyseal region of the femur.  When 
the animals were correctly positioned, the blunt blade was dropped onto the 
bone, similar to the action of a guillotine, producing a three point bending that 
was carried onto the fixation pin. 
 
  
Figure 5. Diagram of Fracture Machine. (Left) Computer scale model of murine 
fracture device with an adjustable mass shaft and stopping thumbwheel held by 
electromagnet above adjustable height base; striker impacts mouse femur held in 
place by mouse positioning system. (Right) Photograph of built prototype with 
electromagnet foot pedal switch, dimensions are 37’’x12’’x12’’ 
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Figure. 6. Diagram of Mouse Positioning System in Fracture Machine. 
Mouse torso rests in half-pipe and swivels on a 1201 arc track depending on 
desired fracture leg, femur is positioned perpendicular to striker using anvil 
notches and entire system is vertically adjustable using a four-post bolt system to 
adjust velocity at impact. (Right) Photograph of built mouse positioning system. 
Figures 5 and 6 from (Marturano et al., 2008) 
This blunt trauma produced a single transverse closed fracture.  Initial 
assessment of the fracture was made by gentle palpation.  Confirmation of the 
fracture with no pin retraction was accomplished utilizing a dental X-ray unit that 
was purchased from Gendex, Inc. and was housed in the LASC procedure room.  
X-rays were taken at a setting of 60kV for 0.16 seconds using Kodak Ultra Speed 
DF-50 Size 4 films. Animals that did not have a single transverse fracture were 
anesthetized again and placed on the fracture machine.  A second X-ray was 
taken to confirm fracture.  
  
Post-Operative Treatment 
 Immediately after regaining consciousness from anesthesia, the mice 
were monitored until they were able to walk and then were returned to a new 
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cage to feed and drink.  The animals were monitored the next day and given 
injections of buprenorphine at 0.1 mg/kg as an analgesic.  The mice were 
examined daily for signs of nerve damage, pin retraction, and any signs of failure 
to recover from injury.  The mice were subsequently removed from the 
phosphate deficient diet after the prescribed time of their enrollment group and 
returned to a normal diet for the duration of the experiment. 
 
Femora Harvesting  
 Euthanasia was accomplished by carbon dioxide inhalation.  The animals 
were individually placed in an approved chamber and a carbon dioxide flow rate 
of 20% air displacement per minute was started.  Terminal cardiac bleeding after 
carbon dioxide asphyxiation was also performed and the blood was placed on ice 
and centrifuged. Cervical dislocation was performed as the secondary 
euthanasia procedure, if the animals were not terminally bled.  The blood plasma 
was extracted and frozen for each animal for further studies evaluating the 
phosphate levels of the blood. X-rays were taken immediately following cervical 
dislocation utilizing a Faxitron MX-20 Specimen Radiography System for a time 
of 40 seconds at 30kV and a distance of approximately 13 cm.  Kodak BioMax 
XAR Scientific Imaging Film was used.   
 A small incision was made in the skin surrounding the right femur and the 
superficial layer of skin was removed from the muscle.  The femur was then 
harvested by means of a hemipelvectomy as well as disarticulation of the knee.  
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The spinal needle pin was removed using forceps and the surrounding soft tissue 
was removed from the femur using a scalpel.  The callus samples that were 
designated for micro-CT, CECT and mechanical testing were removed whole and 
dissected of surrounding tissue then wrapped in gauze and frozen at -80° Celsius 
until they could be scanned and analyzed. For the samples designated for RNA 
extraction, the femur was cut proximal and distal to the callus and fracture site 
and callus tissues were frozen at -80° Celsius until the time of RNA extraction.  
 
RNA Extraction 
 Femur callus samples were kept in liquid nitrogen when removed from the 
-80° Celsius freezer.  The samples were disrupted for molecular analysis using 
the Qiagen Tissue Lyser II®.  The bone was placed in a 2 ml tube filled with 0.75 
ml Qiazol Lysis Reagent®.  The bone and lysis reagent were then frozen in the 
liquid nitrogen. The tube containing the bone was removed from the liquid 
nitrogen and one 2mm stainless steel bead was placed in the tube and the tube 
was placed in the tissue lyser.  The bone was lysed for three minutes at 30 Hz.  If 
samples were not completely lysed, the tube and its contents were re-frozen in 
the liquid nitrogen again and the process was repeated.  Immediately after 
completion of that process, an additional 0.75 ml of Qiazol Lysis Reagent® was 
added and the tube was vortexed for approximately 10 seconds.  This was 
immediately followed by the addition of 200 µl of chloroform.  The solution was 
then vortexed for an additional 10 seconds and placed on ice for approximately 
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two minutes.  The solution was then briefly vortexed again and centrifuged at 
14000 RPM and 4° C for 15 minutes.  The aqueous phase was transferred to a 
new 1.5 ml tube containing an equal volume of isopropanol.  The tube was 
inverted and shaken several times until the liquid cleared and centrifuged again 
at 1400 RPM and 4° C for 30 minutes.  The supernatant was removed and 
washed with 500 µl of 70% ethanol and centrifuged at 14000 RPM and 4° C for 5 
minutes. This ethanol washing process was repeated and the ethanol was 
removed.  The 1.5 ml tube was left turned upside down and leaned against a test 
tube rack on a kimwipe on the bench top for approximately 40 minutes to dry the 
pellet containing the RNA.  The pellet was then dissolved in between 30 and 50 
µl of RNase-free water depending on the size of the pellet and stored at -80° 
Celsius until cDNA generation.  
 
cDNA Generation & qPCR Reaction 
The extracted RNA was thawed and a total of 2 µg was increased to a 
volume of 10.4 µl with RNase-free water in a 0.2 ml PCR tube. The reverse 
transcriptase reaction was carried out using the following reagents from the 
Taqman Reverse Transcription Kit®: MgCl2, dNTP Mix, 10X RT Buffer, and 
Random Hexamers.  The reagents were vortexed and the reverse transpcriptase 
enymes were added along with an RNase inhibitor.  The 10.4 µl of RNA was 
added to 19.6 µl of the reverse transcription polymerase chain reaction reagents 
for a total of 30 µl and lightly vortexed.  The tubes were placed in a thermal cycler 
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to run the PCR cycle as follows: 25° C for 10 minutes, 37° C for 60 minutes, 95° 
C for 5 minutes, and held at 4° C. The cDNA samples were then diluted 1:50 in 
RNase-free water and stored at -20° C until use. 
Quantitative real-time polymerase chain reaction (qPCR) was performed 
with Taqman MGB expression assays® (Applied Biosytems, Foster City, CA, 
USA) using an ABI 7700 Sequence Detector® (Applied Biosystems).  Samples 
were run in triplicate and normalized to 18s rRNA in the same sample.  The fold 
change in expression was normalized to samples from unfractured control 0 day 
B6 mice.  Two animals from the phosphate deficient C3 strain (one from the 21 
day group and another from the 28 day group) were excluded from the study due 
to low quality RNA and low expression of the 18s rRNA.  
 
qPCR Gene Information: Chondrogenesis 
The genes under investigation involved in chondrogenesis are Sox 9 
(SOX9), collagen type II alpha 1 (COL2A1), Aggrecan (ACAN) and Collagen type 
10 alpha 1 (COL10A1). These genes were chosen because each gene has 
expression at specific stages of cartilage development during fracture healing in 
control mice and therefore will serve to elucidate clear differences in expression 
within the phosphate deficient mice. Sox 9 is expressed in all chondroprogenitor 
cells and differentiated chondrocytes except hypertrophic chondrocytes (Yuko 
Mori-Akiyama et al., 2003) therefore, transcription factor Sox 9 controls the 
progression of chondrogenesis first from the earliest commitment stage. Both 
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collagen type II (Col2a1) and Aggrecan (ACAN) are subsequent downstream 
targets of Sox 9.  Hypertrophic chondrocytes secrete collagen type X (Col10a1) 
during the last stages of endochondral ossification (Gerstenfeld et al., 2006).  
 
qPCR Gene Information: PTHrp 
PTHLH codes for the protein PTHrP. PTHrp acts on a G protein–coupled 
receptor, the PTH/PTHrP receptor, synthesized at low levels on flat, proliferating 
chondrocytes and at high levels in very late proliferating chondrocytes and 
prehypertrophic chondrocytes. PTHrP acts to keep the chondrocytes in the cell 
cycle (Kronenberg et al., 2007). Therefore PTHrP can be thought of as the 
regulator of initiation of endochondral bone ossification. 
 
qPCR Gene Information: Osteogenesis 
The bone genes we studied were transcription factor osterix (OSX), 
osteocalcin (OC) and dentin matrix acidic phosphoprotein 1 (DMP1). OSX is a 
gene that produces osterix, a transcription factor necessary for the progression 
and differentiation of mesenchymal stem cells to mature osteoblasts (Zhang et 
al., 2011). DMP1 is a gene in osteoblasts that when translated produces dentin 
matrix acidic phosphoprotein which is an extracellular matrix protein necessary 
for the mineralization of bone (Narayanan et al., 2003). During osteoblast 
maturation, the DMP becomes phosphorylated and is then exported to the 
extracellular matrix where it will orchestrate bone matrix mineralization 
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(Narayanan et al., 2003). OC expression in osteoblasts is typically used as a 
marker for the development of bone…this gene produces osteocalcin, which aids 
in bone mineralization as well as calcium homeostasis (Harada & Rodan, 2003; 
Lee et al., 2007). 
 
Micro-CT Scanning and Contouring 
Micro-computed tomography (micro-CT) is a superior method to plain X 
rays that allows us to determine three dimensional measures of callus and bone 
characteristics that are essential to the study of regains in biomechanical function 
and radiographs are inherently a two-dimensional assessment of the three-
dimensional callus structure. In comparison, computed tomography (CT) 
provides numerous, quantitative, and three-dimensional measurements of the 
structure and mineralization of the fracture callus, and these measurements 
could potentially be related to callus stiffness and strength (Morgan et al., 2008). 
A total of 36 mice (12 of each strain) were used for this part of the study. 
Samples were kept wrapped in PBS soaked gauze and frozen at -80°C 
immediately after harvest until scanning. Femora were thawed and unwrapped 
from gauze and fit into Styrofoam to be stabilized in plastic specimen scanning 
tube. Scans were performed using a Scanco micro-CT 40 system (Scanco 
Medical, Basserdorf, Switzerland) at 12 um/voxel resolution with 200 ms 
integration time under conditions of 70(kVp) and 114 (mA). Reference lines were 
adjusted manually on individual bones to include the entire callus area. 
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Transverse images were reconstructed digitally to generate a 3D image of the 
callus. Analyses were carried out using Scanco Medical software. A global 
threshold algorithm was used to apply a fixed constant threshold to all specimens 
(Morgan et al., 2008). The contouring routine was included in the system 
software and requires the user to supply an initial guess for the inclusion 
boundary for the callus and the exclusion boundary for bone and bone 
fragments. The threshold value is approximately to 45% of the attenuation of 
mature cortical bone in the cohorts of specimens from the three strains of mice 
examined in this study which corresponded to a mineral density of 680.728 
mgHA/cm3 for the AJ strain, 624.796 mg HA/cm3 for the B6 strain and 659.494 
mgHA/cm3 for the C3 strain was used to distinguish mineralized tissue from 
unmineralized and partially mineralized tissue. Three samples from the B6 group 
were excluded from scanning due to their fractures being too distal for analysis.  
 
Micro-CT analysis 
The following measures of callus structure and composition were 
evaluated from the micro-CT image data for each specimen: total callus volume 
(TV); mineralized callus volume (BV); callus mineralized volume fraction (BV/TV); 
tissue mineral density (TMD); standard deviation of mineral density (TMD.SD); 
Bone Mineral density (BMD); and bone mineral content (BMC, defined as the 
callus BV multiplied by TMD). Tissue mineral density is calculated as average 
density of mineralized tissue pixels within the contours that are above the applied 
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threshold determined by earlier evaluation. In contrast, bone mineral density is 
the average density of all pixels within the applied contours. Prior to computing 
the values of each of these outcome measures, a Gaussian filter (sigma = 0.8, 
support = 1.0) was applied for noise reduction. Calculation of TMD, TMD.SD, and 
BMC was made possible by density calibration data obtained from scans of a 
hydroxyapatite (HA) phantom provided by the system manufacturer (Morgan et 
al., 2008).  
 
Mechanical Testing 
Following micro-CT scanning, the proximal and distal ends of the femora 
were potted using polymethyl methacrylate (PMMA) in endcaps consisting of 10 
mm lengths of square aluminum tubing (10 × 10 mm2). Care was taken to keep 
the specimens hydrated with 1X PBS during preparation, to center the bones 
within each casing, and to align the endcaps to each other. Bones were held 
centered by forceps clamped to a clamp stand (See Figure 7). After the PMMA 
dried in the first casing the second casing was held in place using an L bar and 
rubber bands to keep the castings flush against the bar (See Figure 7). The 
gauge length was defined as the length of the callus that spanned the distance 
between the two endcaps from the tops of the dried PMMA. It was calculated as 
the average of four measurements taken at 90° increments around the specimen 
circumference. Specimens were mounted in the testing system (MT55, Instron, 
Norwood, MA) by securing the endcaps in the system grips with thumb screws 
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Angular displacement (twist) was applied at the rate of 0.5°/second until failure. 
This rotation was applied such that the distal end of the femur rotated inward 
relative to the proximal end. Figure 7 shows the potting technique used for the 
mechanical testing procedure and Figure 8 shows the torsional testing system. 
  
 
Figure 7. Femur PMMA Potting Technique. These are pictures showing the 
method by which the femurs were centered and potted in PMMA for testing. 
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Figure 8. Torsional Testing System. Photo of instrument used for torsional 
testing of all femur samples. 
Torque was measured with a 2.25-N·m transducer and angular 
displacement with an optical encoder (Morgan et al., 2008). Torsional strength 
was defined as the maximum torque sustained by the specimen. Torsional 
stiffness was calculated as the slope of the linear portion of the torque-twist 
curve, where the gauge length normalized twist. Torsional rigidity is the force 
applied per radian of turn. Work to failure is a measure of the force applied until 
the angle at which structural failure occurred. There were 5 samples (1 AJ, 1 C3, 
and 3 B6) excluded from testing due to either fractures being too distal to pot or 
damage to the callus during potting.  
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Contrast Agent Enhanced CT Scanning 
A total of 27 mice (9 per strain) were used for this portion of the study. A 
scan of each callus was performed in PBS with protease inhibitor using a micro-
CT system (micro-CT40, Scanco Medical AG, Brüttisellen Switzerland) before 
and after incubation in the contrast agent. The resolution, peak voltage, current, 
and integration time were 12 µm/voxel, 70 kV, 114 mA, and 200 ms, respectively. 
Calluses were incubated in CA4+ (Fig. 9) for 8 hours at room temperature 
between scans. Six samples were excluded form the study (1AJ, 3B6, and 2 C3) 
due to poor fracture quality or damage to the callus during analysis. 
 
Figure 9. Contrast Agent molecular Structure. Figure from Hayward et al., 
2013 
 
 
CECT Analysis 
This method is modified from that presented in Hayward et al., 2013. 
Stacks of between 398 and 547 transverse dicom files from the pre- and post-
incubation scans of each sample, centered on the original location of the 
corresponding dicoms, were aligned with each other using registration (Amira 
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5.5, Visage Imaging, Andover, MA). Following registration, the pre-incubation 
images were subtracted from the registered, post-incubation images. The 
resulting subtracted images were then analyzed to distinguish cartilage from the 
non-cartilaginous tissues. The CECT images were examined to determine the 
range of intensities (upper and lower thresholds) in the subtracted images that 
identified cartilage. These thresholds were calculated by an analysis of the 
histogram of intensities for each sample. Upper thresholds were only applied 
when bone was present in the callus. Each histogram was deconstructed into the 
sum of either three or four normal distributions corresponding to intensities that 
appeared to represent background noise, PBS and non-cartilaginous soft tissues, 
cartilage, and bone. First, the thresholds were chosen so that >95% of the voxels 
with a given intensity over the lower threshold and >50% of the voxels with a 
given intensity under the upper threshold corresponded to the cartilage 
distribution.  
 
2D and 3D Analysis of the CECT Images 
The volumes of the callus, cartilage, cortex, and newly mineralized tissue 
were calculated for each sample. Contouring of the callus and cortex was 
performed manually using the Scanco software. The callus and cortex 
boundaries were defined periodically along the length of the callus and then 
linearly interpolated onto the intervening slices (Hayward et al., 2013). Voxels 
that were within the callus, outside the cortex, and of intensity >45% of the 
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cortex’s mean intensity was identified as newly mineralized tissue. 
 
Statistical Methods  
Statistical analysis was performed using Microsoft Excel and JMP Pro 
Software.  Group averages for qPCR data was computed along with standard 
deviation and standard error.  Graphs were generated for mRNA expression of 
selected genes, including standard error bars. Significant differences in 
expression between strains and against control mice were determined using 1 
and 2 way ANOVAs followed by Tukey post hoc test to compare means when a 
factor was found to be significant. For micro-CT, mechanical testing and CECT 
analysis, significant differences in expression between strains and against control 
mice were determined using JMP 11.0, Pro with One and Two way ANOVAs 
followed by Tukey post hoc test to compare means when a factor was found to 
be significant. 
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RESULTS 
 
qPCR analysis: Chondrogenesis  
 Genes were chosen for analysis based on their role in chondrogenesis, 
endochondral bone growth or osteogenesis. The genes under investigation that 
are involved in chondrogenesis were Sox 9 (SOX9), collagen type II alpha 1 
(COL2A1), Aggrecan (ACAN) and Collagen type 10 alpha 1 (COL10A1). Figure 
10 shows the relative fold change in expression for a group of mRNAs that are 
expressed during the progression of the chondrocyte differentiation.  All results 
are normalized to unfractured B6 control bones and the gene expression profiles 
are presented in temporal order of the progression of chondrocyte differentiation 
and endochondral bone growth initiation.  
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Figure 10.  qPCR Analysis: Chondrogenesis.  These graphs show the 
temporal gene expression profiles of four genes (SOX 9, COL2A1, ACAN, & 
COL10A1) associated with chondrogenesis. In all graphs, the control group is the 
black dotted line.  
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Among the cartilage genes relatively few differences were significant 
within the phosphate deficient group between the different strains. Sox 9 
expression in C3 mice seemed to be delayed relative to the B6 and AJ strains 
with significantly less expression at the 5 day time point (p=0.0351). Similarly 
with COL2A1, the only significant difference observed was the earlier expression 
at day 3 in the B6 mice relative to the other strains (p<0.002) as well as a second 
significant peak at 18 days in the AJ strain relative to the other strains 
(p=0.0198). With respect to ACAN, the only significant finding was the increased 
expression at day 14 in the B6 relative to the other strains (p=0.0207) indicating a 
broader time frame of expression in the B6 mice. Lastly, Collagen 10a 1 showed 
similar expression patterns and significant differences with B6 showing higher 
expression at the 3 day time point (p=0.0046) as well as a significant second 
peak in AJ expression at 18 days post fracture (p=0.004).  
When comparing expression against controls, however, there were many 
significant differences in expression indicating that the phosphate deficiency had 
a significant effect on chondrogenesis.  Using Sox 9 to assess the initiation of 
chondrogenesis showed considerable variation between the strains. Sox 9 
expression in the B6 phosphate deficient group was significantly higher than in 
the controls for all time points (all p values < 0.05) whereas the mice in the 
phosphate deficient AJ strain seem to have a similar pattern of expression to 
controls only differing slightly in the temporal breadth of expression. The 
phosphate deficient C3 mice had delayed expression of Sox 9 relative to controls 
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as well as a second smaller peak at day 18 (p=0.0210). Collagen 2a1 expression 
was significantly decreased relative to control mice in both the phosphate 
deficient B6 and C3 strains at the earlier time points of 7 and 10 days (p values 
<0.003) however, we observed an increase in expression in these strains over 
controls at the later time points of 21 and 28 days post fracture (p<0.0009) after 
phosphate had been returned to the diet. Aggrecan expression showed a similar 
pattern to Col2a1 with a significant decrease in expression in all strains relative 
to controls at the early time points of 5, 7 and 10 days post fracture (p<0.003) 
with only phosphate deficient B6 mice showing increased expression over 
controls at the later time points of 14 days post fracture and beyond (p=0.0025). 
Collagen 10a1 showed the most dramatic difference from controls with 
expression decreased in all strains relative to controls. These results then 
suggest that while not blocking the initiation of chondrogenesis, that phosphate 
restriction clearly delayed the progression and full expression of the maturation of 
the cartilage with the C3 and AJ strains being most profoundly affected. 
 
qPCR analysis: PTHrp Expression 
In order to examine how phosphate deficiency affected one of the master 
regulators of chondrocyte maturation, the expression of PTHrP was next 
assessed.  PTHLH codes for the protein parathyroid hormone related protein 
(PTHrP). Figure 11 shows the relative fold change in expression of the genes 
that control PTHrP. All results are normalized to unfractured B6 control bones. 
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Figure 11.  qPCR Analysis: PTHrp expression.  These graphs show the 
temporal gene expression profiles of PTHrp in the AJ, B6 and C3 strains. PTHrP 
is associated with initiation of endochondral bone ossification. In all graphs, the 
control group is the black dotted line.  
 
 
The phosphate deficient B6 mice expressed the PTHrP gene at a 
significantly higher level that the other strains (p<0.05). Also, the B6 strain 
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expressed higher levels of PTHrP compared to the AJ and C3 strains at the later 
time points of 10, 21 and 28 days post fracture (p values <0.02). When compared 
to controls all strains showed increased expression as well as a significant shift in 
expression of the gene to the later time points (p<0.03). 
 
qPCR analysis: Osteogenesis 
The remaining genes studied are markers for the different stages of 
osteogenesis. Figure 12 presents the assessment of the mRNA expression for 
the markers of different stages of osteogenesis. Similar to our analysis of 
chondrogenesis, three genes spanning the progression of osteogenic 
differentiation were assessed. The figure shows the relative fold change in 
expression of the genes related to osteogenesis.  All fold changes in expression 
are normalized to unfractured B6 control bones.  
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Figure 12.  qPCR Analysis: Osteogenesis.  These graphs show the temporal 
gene expression profiles of three genes (OSX, DMP1, & OC) associated with 
osteogenesis. In all graphs, the control group is the black dotted line.  
 
Similarly to the expression patterns observed in the cartilage genes, there 
were few significant differences in expression between the individual mouse 
strains in the phosphate deficient group. Osterix showed no significant 
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differences in expression across the groups. The phosphate deficient B6 mice 
showed significantly higher expression of osteocalcin at 3 days post fracture 
(p=0.0474) whereas later at 21 days (p=0.0369) and 35 days (p=0.0497) the C3 
group has significantly higher expression. This indicated a later shift in 
expression of the phosphate deficient C3 strain relative to the AJ and B6 mice. 
There was no significant difference in DMP1 expression between the AJ and C3 
strains for any time points studied, however, DMP1 expression was higher at all 
time points for the phosphate deficient B6 strain relative to AJ and C3 (all p 
values <0.05).  
When the bone genes were observed relative to controls, many significant 
differences in expression occurred with respect to both temporal expression as 
well as fold change in expression. There was a significant shift in temporal 
Osterix expression seen in all three strains. At the early time points of 3 days and 
5 days post fracture the control group in all strains had higher expression (all p 
values <0.05). However, at the later time points of 18, 21, 28 and 35 days post 
fracture all phosphate deficient strains displayed higher expression of the gene 
over controls (all p values < 0.05). For osteocalcin expression, the trend of later 
expression can also be seen at 14 days post fracture as the control mice had an 
overall higher expression of osteocalcin at this day, but at day 21 the phosphate 
deficient group overall had greater expression relative to controls. Lastly, DMP1 
expression in all phosphate deficient strains also exhibited a delay as well as an 
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overall increase in expression relative to controls at the 21, 28 and 35 day time 
points (all p values<0.03). 
 
Mechanical Testing Analysis  
  Important indicators of proper fracture healing are measures that show the 
regains in biomechanical function of the healing bone. Upon torsional testing of 
the harvested bones, we studied max torque, work to failure, rigidity, stiffness 
and twist at failure of each sample. Figure 13 shows a comparison between 
strains and against controls for measures of max torque and work to failure.  
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Figure 13. Mechanical Testing (I): These graphs show the maximum torque 
and work to failure values for all three strains for the phosphate deficient groups 
and the controls. All mice were harvested at the day 21 post fracture time point. 
The asterisks (*) indicate a significant difference between the phosphate deficient 
and control groups. 
 
 
 There were no significant differences observed between the three strains 
in the phosphate deficient group for max torque or work to failure. However, there 
* * 
* 
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were significant differences between the phosphate deficient and control groups. 
For the AJ and B6 strains, the max torque was significantly higher for the bones 
of the phosphate deficient group (all p values < 0.005). Also, the B6 phosphate 
deficient group showed a significantly higher work to failure average relative to 
the B6 controls (p< 0.005). The AJ and C3 mice of the control and phosphate 
deficient groups showed no significant difference in work to failure, however, the 
phosphate deficient AJ mice showed a similar pattern of higher work to failure 
relative to control AJ mice. Figure 14 shows a comparison between strains and 
against controls for rigidity, stiffness and twist at failure.  
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Figure 14. Mechanical Testing (II): These graphs show the stiffness, rigidity, 
and twist at failure values for all three strains for the phosphate deficient groups 
and the controls. All mice were harvested at the day 21 post fracture time point. 
The asterisks (*) indicate a significant difference between the phosphate deficient 
and control groups. 
 
* 
* 
* 
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 There were no significant differences observed between the three strains 
in the phosphate deficient group for rigidity, stiffness or twist at failure. However, 
there were significant differences between the AJ strains of the phosphate 
deficient and control groups. The AJ mice from the phosphate deficient group 
showed higher rigidity and stiffness when compared to controls (p< 0.005). There 
were no significant differences between the phosphate deficient and control 
groups for the B6 and C3 strains for rigidity and stiffness, but they showed similar 
patterns with the phosphate deficient group on average being higher in both 
measures in both groups. Lastly, the AJ control mice also showed a significant 
difference from the phosphate deficient group regarding twist at failure measures. 
The phosphate deficient AJ mice showed a significantly lower twist at failure 
(p<0.0009) when compared to controls. There were no significant differences 
between the phosphate deficient and control groups for the B6 and C3 strains for 
twist at failure, but the C3 group showed similar patterns to the AJ group with the 
phosphate deficient group showing a lower average value in this measure.  
 
Micro-CT analysis 
 Figure 15 below shows a comparison between strains and against 
controls for BV, TV and BV/TV.  
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Figure 15. Micro-CT Analysis (I): These graphs show the bone volume of the 
callus(mm3), total volume of the callus (mm3) and the ratio of these measures 
(BV/TV) for all three strains for the phosphate deficient groups and the controls. 
All mice were harvested at the day 21 post fracture time point. The letters above 
the bars indicate a significant difference between strains of the phosphate 
deficient group. The asterisks (*) indicate a significant difference between the 
phosphate deficient and control groups. 
 
A 
B* 
B 
B 
B 
A 
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 When compared within the phosphate deficient group, significant 
differences were observed. The B6 strain exhibited both a significantly higher 
bone volume and total volume relative to the AJ and C3 strains (p<0.0001). 
There were no significant differences between strains of the phosphate deficient 
group for ratios of bone volume to total volume (BV/TV). When compared to 
controls the only observed significant difference was a slightly larger bone 
volume observed in the AJ mice of the phosphate deficient group verses control 
AJ mice (p=0.0341). Compared to controls no other significant differences were 
found for TV or BV/TV.  
Figure 16 below shows a comparison between strains and against 
controls for BMC, TMD, BMD and BMD.SD.  
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Figure 16. Micro-CT Analysis (II): These graphs show the bone mineral content 
(BMC) of the callus (mgHA), tissue mineral density (TMD) of the callus 
(mgHA/cm3), bone mineral density (BMD) of the callus (mgHA/cm3) and the bone 
mineral density standard deviation for all three strains for the phosphate deficient 
groups and the controls. All mice were harvested at the day 21 post fracture time 
point. The letters above the bars indicate a significant difference between strains 
of the phosphate deficient group. The asterisks (*) indicate a significant 
difference between the phosphate deficient and control groups. 
B 
B 
A B A * C * 
B 
B 
A A 
B * 
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Within the phosphate deficient group the B6 mice had significantly higher 
BMC relative to the AJ and C3 strains (p<0.001). Also, all three phosphate 
deficient strains differed significantly from each other in tissue mineral density 
with AJ being the highest, followed by C3 and B6 being the least dense 
(p<0.0001). Bone mineral density followed a similar trend with the AJ strain 
significantly higher than the C3 and B6 strains (p<0.0001). The difference in BMD 
between the B6 and C3 mice was not significant, however, it followed the trend of 
C3 being denser than the B6 mice (p=0.0734). Lastly, there were differences 
between the strains in bone mineral density standard deviation. Both the 
phosphate deficient AJ mice and the C3 mice had a significantly higher standard 
deviation relative to the B6 strain (p<0.0001).  
 When compared to controls, there were some significant differences and 
trends observed. There was no significant differences observed in BMC, 
however, the AJ phosphate deficient group showed on average higher bone 
mineral content relative to controls (p=0.0976). With regard to TMD, both the AJ 
and B6 control mice showed a significantly higher tissue mineral density 
compared to the phosphate deficient mice (p< 0.0005). There was no significant 
difference in TMD between the C3 mice of phosphate deficient and control 
groups. Between the control and phosphate deficient groups on average the 
phosphate deficient mice had a higher bone mineral density over all three strains. 
Lastly, the standard deviation of bone mineral density was significantly higher in 
the phosphate deficient B6 mice relative to controls (p< 0.005). There was no 
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significant difference found between the standard deviations of bone mineral 
density for the AJ and C3 phosphate relative to controls however they both on 
average had higher standard deviations.  
 
Contrast Enhanced CT Analysis 
 Assessment of the early stages of fracture healing via X-rays and 
computed tomography is limited by the low radio-opacity of cartilage (Hayward et 
al., 2013). Using a positively charged contrast agent, CA4+, we can look for 
differences between the three strains of mice in the distributions of cartilage as 
well as non-cartilaginous soft tissues in the newly formed fracture callus.  
Using this method we measured both cartilage area and cartilage volume 
within the healing fracture calluses. Figure 17 shows the Cartilage area and 
Cartilage volume between strains and then relative to controls.  
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Figure 17. CECT Analysis (I): These graphs show cartilage area and volume for 
all three strains for the phosphate deficient groups and the controls. All mice 
were harvested at the day 21 post fracture time point. 
 
Between the different strains within the phosphate deficient group the C3 
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mice had the highest cartilage area but the AJ mice had on average more 
cartilage volume and relative to the other strains. Overall, there were no 
significant differences between phosphate deficient mice and controls in terms of 
cartilage area or cartilage volume, however, in general the trend showed that in 
both the C3 and AJ mice there was on average more cartilage present than in 
controls and the phosphate deficient B6 strain had on average less cartilage than 
controls. 
Figure 18 shows the callus tissue mineral density, callus mineralized 
tissue volume and callus bone mineral content between strains and then relative 
to controls.  
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Figure 18. CECT Analysis (II): These graphs show the callus bone mineral 
content (BMC, mgHA), callus tissue mineral density (TMD, mgHA/cm3), callus 
mineralized tissue volume (mm3) and mineralized callus area for all three strains 
for the phosphate deficient groups and the controls. All mice were harvested at 
the day 21 post fracture time point. The letters above the bars indicate a 
significant difference between strains of the phosphate deficient group. The 
asterisks (*) indicate a significant difference between the phosphate deficient and 
control groups. 
A* 
A 
B 
B 
A 
B 
B 
B* B* 
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Between the different strains of the phosphate deficient group, the AJ 
mice showed a significantly higher callus TMD compared to the C3 and B6 
strains with C3 less dense than AJ but higher than B6 (p<0.005). The B6 mice 
showed a significantly higher callus mineralized tissue volume relative to the 
other strains (p<0.0001). Also, the B6 strain showed a significantly higher bone 
mineral content when compared to the other strains (p<0.0005).  
 When compared to controls, there were significant differences observed 
for callus tissue mineral density. For all strains the control mice showed a higher 
callus tissue mineral density relative the phosphate deficient mice (all p values 
<0.005). There were no significant differences observed for callus mineralized 
tissue volume or bone mineral content for any of the strains relative to controls. 
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DISCUSSION 
 
Study Findings 
The skeletal abnormalities seen in hypophosphatemic disorders highlight 
the importance of phosphate in growth plate maturation and skeletal 
mineralization (Drezner et al.,1980). Furthermore, hypophosphatemia has been 
shown to produce abnormalities in fracture healing (Wigner et al., 2010). The 
aims of this study were to specifically determine how prolonged phosphate 
deficiency affects fracture healing and to determine if fracture healing can be 
restored upon reintroduction of phosphate into the diet. We further wanted to 
determine if genetic variation would have any effect on how phosphate affects 
fracture healing. 
When looking at the mRNA expression profiles of the control mice and 
those from mice on the phosphate deficient diet, there were significant 
differences observed for all strains when compared with controls. Both the 
chondrogenesis and osteogenesis genes seemed to be affected in similar ways 
in response to the diet independent of genetic background. The most striking 
pathologic abnormality in the hypophosphatemic calluses was the marked 
impairment in progression of chondrogenic differentiation of the mesenchymal 
cells that are recruited to the fracture callus (Wigner et al., 2010). The result in 
this study similarly showed deficiencies in chondrogenesis and especially 
showed a decrease in expression of the later chondrogenesis marker genes. 
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This conclusion is based on the largely unaffected Sox 9 expression when 
compared to the controls and the marked increased in expression in the B6 mice. 
This may be due to Sox 9 being integral to chondrogenesis induction with 
expression typically occurring earlier in the time course of the phosphate 
deficiency and thus is not as affected by the dietary restriction.  However, as 
chondrogenesis progressed, the expression of later markers of chondrocyte 
differentiation showed decreased expression in all three strains relative to 
controls.  Both aggrecan and Col10a1 expression were markedly depressed in 
the phosphate deficient group. This indicated that the prolonged phosphate 
deficiency had a profound inhibitory effect on normal chondrocyte maturation.   
Another important difference between groups was the significant delay in 
PTHrP gene expression. This gene is an essential paracrine regulatory factor 
that controls both chondrocyte proliferation and maturation (Kronenberg et al., 
2007). Also, it is one of the earliest markers of initiation of endochondral bone 
ossification. In control groups, it was shown to have peak expression within the 
first week after fracture. Interestingly, all three strains of mice in the phosphate 
deficient groups showed a delay in expression until phosphate was returned to 
the diet as well as significantly higher expression of the gene upon phosphate 
reintroduction into their diet.  These results show that the phosphate dietary 
levels had a clearly definable regulatory effect on the local paracrine and 
autocrine mechanisms that control endochondral ossification.  Furthermore, 
when phosphate was returned to the diet, the expression of PTHrP increased to 
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much higher levels in the phosphate deficient mice than that seen in the control 
mice. This suggests that there was a compensatory response leading to a burst 
of mineralization as the chondrocytes within the callus corrected the phosphate 
deficiency leading to the stabilization in the fracture gap. 
Similarly to PTHrP expression, many of the osteogenesis genes also 
showed a delay in expression as well as an overall increase in expression 
relative to controls. Both these trends can be seen particularly in the expression 
patterns of Osterix and DMP1. All three strains of the phosphate deficient group 
showed delayed expression of these genes until after the mice were returned to 
a normal diet.  Osteocalcin showed a later initiation in both the phosphate 
deficient C3 and AJ mice as well as elevated expression in the phosphate 
deficient B6 mice. These findings also indicate a compensatory response to 
mineralize cartilage and stabilize the fracture.  
 Perhaps the most interesting results of the study were the effects of the 
phosphate restriction on the mechanical properties of the newly healed bone.  In 
all three strains of the phosphate deficient group the bones appeared to be 
mechanically stronger than the controls. All three strains showed a significantly 
higher max torque and all but the C3 mice showed a higher work to failure 
relative to controls. Also, all three strains of the phosphate deficient group 
showed higher stiffness and rigidity relative to controls.  
Though these results may seem unexpected due to other studies showing 
deficits in healing with phosphate deficiency, when observed with the increase in 
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expression of PTHrP as well as the osteogenesis genes there is a plausible 
explanation. Due to the already built deficit of phosphate, when the phosphate is 
re-introduced into the diet the chondrocytes are released from their blockade in 
development and progress immediately to mineralized bone to stabilize the 
fracture. As the bone is healing, the majority of the mineralization is localized at 
the fracture gap creating areas of dense mineralization at the fracture site within 
the cortical bone. This change in healing creates mineralized tissue that is more 
brittle than that of the control mice who had an undisturbed progression of 
healing.  When mechanically tested, this new more dense mineralized tissue 
around the fractured cortical bone appears to resist torsional strain more than the 
tissue of the controls. Furthermore, it shows an apparent higher rigidity and 
stiffness as well as an apparent decrease in twist at failure. These changes 
indicate that the compliance or flexibility of the bone in the phosphate deficient 
group has decreased relative to controls due to the more concentrated spatial 
mineralization. 
 To further corroborate our mineralization change we needed to look at 
mineralization measures found from 3D micro-CT analysis of the fracture 
calluses. Interestingly, we observed that on average the bone mineral density 
was just a little higher in the calluses of the phosphate deficient groups. This is 
consistent with our conclusion of the relatively higher localized mineralization 
near the fracture gap creating a more densely mineralized tissue that would bring 
up the observed average for the groups. Moreover, the bone mineral density 
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standard deviation was found to be higher in the phosphate deficient groups thus 
indicating that the distribution of mineralized callus was more heterogeneously 
localized in the phosphate deficient group with some regions showing greater 
mineralization while others showing lesser mineralization. This could be the 
effect of the concentrated mineralization at the fracture gap and lower 
mineralization further out in the callus from the cortical bones.  
 Lastly, the contrast agent enhanced CT (CECT) results showed some 
deficiencies in cartilage mineralization in the phosphate deficient mice. On 
average, we observed a trend that the phosphate deficient mice tended to retain 
slightly more cartilage in the healing callus relative to control mice. This finding is 
consistent with the finding that the callus tissue mineral density (TMD) of the 
phosphate deficient group was slightly lower than that of controls. This is likely 
due to the presence of the extra cartilage that will lower the apparent mineral 
density of the callus as a whole.  
 
Conclusion and Future Directions 
Taken all together, our results support the hypothesis that phosphate 
deficiency impairs the progression of normal fracture healing in our mouse 
models. Furthermore, we have uncovered new and interesting data about the 
characteristics of the newly healed bone that is formed upon re-introduction of 
phosphate into the diet after deficiency. These findings suggest that even small 
perturbations in the diet not only affect normal healing progression but also when 
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the deficit is corrected there may be added effects to bone healing that differ from 
the normal fracture healing process. 
In order to gain more understanding of the results, more investigations 
need to be done with this cohort of samples to more clearly show the effect of 
phosphate deficiency on fracture healing.  First, in order to confirm the relative 
phosphate deficiencies of the different mice in the groups, the serum of the blood 
that was extracted during the terminal bleeding of the mice should be evaluated.  
This would allow researchers to see if any differences in sample data could be 
attributed to different levels of hypophosphatemia between the mice. Also, further 
investigation of the distribution of mineralized cartilage could be achieved by an 
analysis of the polar moment of inertia. The polar moment of inertia will allow us 
to determine how the shapes and/or differences in mineralization affect the 
mechanical properties of the calluses.  With this information we will be able to 
see more definitively if the callus is more densely mineralized closer in to the 
cortical bones relative to control mice.  Next, another important arm of this project 
would be to employ a method of mineralization mapping based on the brightness 
of voxels observed using the micro-CT scans of the calluses.  This would give 
researchers a way to visualize different densities of mineralized tissue relative to 
each other and may show the mineralization closer to cortical bone in the 
phosphate deficient group. Also, histological analysis of the calluses from the 
contrast-enhanced group would help elucidate the mineralization patterns in the 
calluses. 
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Lastly, in terms of this cohort, more mice must be enrolled in each aspect 
of the study because some of the mice used in this experiment had fractures that 
were further distal than the midpoint of the femur. Also, some of the fractures 
showed multiple oblique breaks that fragmented the bone. Both of these types of 
fractures may have led to increased fracture instability during healing and may 
have changed the properties of the calluses relative to controls.   
Beyond this group of mice, analysis of the mechanical testing, micro-CT 
and CECT results from the mice harvested at the 14 day post fracture time point 
at the same 15 day phosphate restriction would be helpful in determining the true 
effects of the re-introduction of phosphate back into the diet of the mice. We 
would expect these mice to show lower strength measures in mechanical testing 
as well as significantly less mineralization when compared to controls. This would 
help our hypothesis regarding the 15 day restriction 21 day time point because 
these mice in theory would not have been given the chance to use phosphate to 
mineralize near the fracture gap. Similarly, investigation of the 21 day time point 
within a group subjected to a 20 day phosphate restriction would help to further 
understand how fracture healing is being affected in these mice. If researchers 
were able to show that at a longer phosphate restriction causes these 21 day 
calluses to have deficits relative to the 15 day restriction calluses, that would help 
to clarify the observed effects on mineralization on the mice from this experiment. 
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